To date, the application of clinical EEG and qEEG have been very limited in psychiatry, although studies suggest effective application in diagnosis, medication response, and treatment selection. ADD symptoms are common to many diagnoses and can often elude detection – however there are for subtypes of ADHD that can be identified by four distinctly different neurobiomarkers on a EEG/qEEG. The following newsletter article will explain which neurobiomarkers for ADHD respond well to medication, which neurobiomarkers are commonly associated with medication failure, and why physicians should incorporate this valuable information into treatment plans.